Medicare Enrolled
Dr. Ashley Langford Tunkle, M.D.
Family Medicine · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Langford Tunkle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Langford Tunkle? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Langford Tunkle
Dr. Ashley Langford Tunkle is a family medicine in Naples, FL, with 20 years in practice. Based on federal Medicare data, Dr. Langford Tunkle performed 21,592 Medicare services across 11,532 unique beneficiaries.
Between the years covered by Open Payments, Dr. Langford Tunkle received a total of $17,891 from 77 pharmaceutical and/or device companies across 992 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Langford Tunkle is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in FL$ $17,891 industry payments
Medicare Practice Summary
Medicare Utilization ↗21,592
Medicare services
Top 1% in FL for family medicine
11,532
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,080 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 8,761 | $18 | $47 |
| Office visit, established patient (30-39 min) | 1,658 | $86 | $264 |
| Blood draw (venipuncture) | 1,264 | $8 | $17 |
| Complete blood count (CBC) with differential | 1,134 | $8 | $16 |
| Comprehensive metabolic blood panel | 1,089 | $10 | $21 |
| Thyroid stimulating hormone (TSH) test | 1,079 | $16 | $34 |
| Annual wellness visit, follow-up | 1,043 | $130 | $267 |
| Lipid panel (cholesterol and triglycerides) | 1,036 | $13 | $27 |
| Annual depression screening | 1,032 | $18 | $38 |
| Vitamin D level test | 742 | $29 | $59 |
| Drug injection, under skin or into muscle | 393 | $10 | $30 |
| Hemoglobin A1c test (diabetes monitoring) | 337 | $9 | $19 |
| Prostate cancer screening; prostate specific antigen test (psa) | 208 | $19 | $39 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 203 | $1 | $3 |
| Flu vaccine administration | 167 | $31 | $64 |
| Injection, zoledronic acid, 1 mg | 165 | $6 | $15 |
| Flu vaccine, high-dose | 162 | $71 | $145 |
| Office visit, established patient (20-29 min) | 72 | $54 | $187 |
| New patient office visit (45-59 min) | 62 | $95 | $347 |
| Vitamin B-12 level test | 61 | $15 | $30 |
| Urine culture, bacterial colony count | 58 | $8 | $16 |
| Automated urinalysis | 53 | $2 | $4 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 51 | $168 | $343 |
| Urinalysis with microscopic exam | 47 | $3 | $6 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 45 | $8 | $30 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 43 | $282 | $575 |
| Pneumonia vaccine administration | 43 | $32 | $64 |
| Urine microalbumin test (kidney screening) | 39 | $6 | $12 |
| Creatinine test (kidney function) | 39 | $5 | $10 |
| Free thyroxine (T4) test | 37 | $9 | $18 |
| Electrocardiogram (EKG), 12-lead | 33 | $10 | $30 |
| Transitional care management services for problem of high complexity | 32 | $215 | $570 |
| Infusion, normal saline solution, 250 cc | 32 | $0 | $1 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 30 | $52 | $132 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 30 | $168 | $342 |
| Infusion into a vein for hydration, each additional hour | 29 | $10 | $26 |
| Iron level test | 25 | $6 | $13 |
| Ferritin level test (iron stores) | 23 | $13 | $27 |
| Folic acid level test | 23 | $14 | $29 |
| Iron binding capacity test | 23 | $9 | $17 |
| Urinalysis, manual | 22 | $3 | $7 |
| Bacterial culture, aerobic | 22 | $8 | $16 |
| Antibiotic sensitivity test | 22 | $8 | $17 |
| Basic metabolic blood panel | 19 | $8 | $17 |
| C-reactive protein test (inflammation marker) | 18 | $5 | $10 |
| Thyroid hormone, t3 measurement, free | 17 | $17 | $34 |
| Transitional care management services for problem of at least moderate complexity | 17 | $158 | $420 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $42 | $107 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 15 | $4 | $11 |
| Removal of impacted ear wax | 11 | $37 | $101 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 11 | $35 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
44.2% medium
55.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,891
Total received (2018-2024)
Avg $2,556/year across 7 years
Top 2% in FL for family medicine
77
Companies
992
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,680 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$210 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,845
2023$2,857
2022$2,443
2021$2,935
2020$2,246
2019$2,815
2018$2,750
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$2,138
Novo Nordisk Inc
$1,375
Janssen Pharmaceuticals, Inc
$1,162
Astellas Pharma US Inc
$1,126
Amgen Inc.
$1,066
Takeda Pharmaceuticals U.S.A., Inc.
$873
Lilly USA, LLC
$784
Merck Sharp & Dohme Corporation
$773
GlaxoSmithKline, LLC.
$752
ABBVIE INC.
$738
AstraZeneca Pharmaceuticals LP
$604
Boehringer Ingelheim Pharmaceuticals, Inc.
$553
Supernus Pharmaceuticals, Inc.
$452
AbbVie Inc.
$428
Novartis Pharmaceuticals Corporation
$336
Corium, LLC
$294
Merck Sharp & Dohme LLC
$258
Sunovion Pharmaceuticals Inc.
$220
Esperion Therapeutics, Inc.
$188
Exact Sciences Corporation
$184
Shire North American Group Inc
$178
Allergan, Inc.
$177
Abbott Laboratories
$176
Sumitomo Pharma America, Inc.
$145
Ironshore Pharmaceuticals Inc.
$128
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$125
kaleo, Inc.
$125
Boston Scientific Corporation
$122
Almatica Pharma LLC
$120
Alnylam Pharmaceuticals Inc.
$103
SANOFI PASTEUR INC.
$100
Teva Pharmaceuticals USA, Inc.
$99
Biohaven Pharmaceuticals, Inc.
$97
IRONSHORE PHARMACEUTICALS INC.
$94
Jazz Pharmaceuticals Inc.
$94
JAZZ PHARMACEUTICALS INC.
$93
TherapeuticsMD, Inc.
$91
Amarin Pharma Inc.
$87
Teleflex LLC
$86
IDORSIA PHARMACEUTICALS US INC
$78
Biohaven Pharmaceutical Holding Company Ltd.
$77
Otsuka America Pharmaceutical, Inc.
$75
Medtronic, Inc.
$74
SANOFI-AVENTIS U.S. LLC
$72
Neos Therapeutics, LP
$66
IBSA Pharma Inc.
$63
AMAG Pharmaceuticals, Inc.
$63
Bayer Healthcare Pharmaceuticals Inc.
$60
VIVUS, Inc.
$55
Tris Pharma Inc
$54
AbbVie, Inc.
$43
Horizon Therapeutics plc
$39
Genentech USA, Inc.
$38
Allergan Inc.
$35
Radius Health, Inc.
$35
SI-BONE, INC.
$34
Amneal Pharmaceuticals LLC
$32
Kaleo, Inc.
$29
Sanofi Pasteur Inc.
$28
Bausch Health US, LLC
$24
Evofem Biosciences, Inc.
$21
Xeris Pharmaceuticals, Inc.
$21
Grifols USA, LLC
$21
OptiNose US, Inc.
$19
Axonics, Inc.
$18
EISAI INC.
$17
DERMIRA, INC.
$16
Avion Pharmaceuticals
$16
Eisai Inc.
$16
Duchesnay USA Incorporated
$15
Nevro Corp.
$15
Braemar Manufacturing, LLC
$14
Arbor Pharmaceuticals, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$13
Adlon Therapeutics L.P.
$12
Currax Pharmaceuticals LLC
$12
Horizon Pharma plc
$12
Top 3 companies account for 26.1% of total payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ADHANSIA XR · AIMOVIG · AIRSUPRA · AJOVY · ANNOVERA · ANORO · AREXVY · AUVI-Q · AZSTARYS · Adzenys XR-ODT · Aimovig · Axonics · Azstarys · BASAGLAR · BELSOMRA · BIJUVA · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · Balcoltra · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cardiac Monitoring Suite · Cologuard Collection Kit · DUEXIS · Dayvigo · Dyanavel XR · ELIQUIS · ELUVIA · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLECTOR · FLUBLOK QUADRIVALENT · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GEMTESA · GRALISE · GVOKE PFS · Horizant · IMVEXXY · INTRAROSA · INVEGA SUSTENNA · INVOKANA · JANUVIA · JARDIANCE · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · Kerendia · LINZESS · LIVALO · LO LOESTRIN FE · LONHALA MAGNAIR · LOREEV XR · LYRICA · Leqembi · Licart · MENACTRA · MOUNJARO · MYDAYIS · MYRBETRIQ · Myrbetriq · NAMZARIC · NEXLETOL · NURTEC ODT · ONPATTRO · Omnia · Osphena · Otezla · Ozempic · PNEUMOVAX 23 · PRADAXA · PRALUENT · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROPEL · PROQUAD · Phexxi · Proclaim Family of SCS IPGs · Prolastin-C Liquid · Prolia · QBREXZA · QELBREE · QSYMIA · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPECTRA WAVEWRITER · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TRADJENTA · TRELEGY ELLIPTA · TRIJARDY XR · TRINTELLIX · TRULICITY · TRUMENBA · Tirosint · Tresiba · Trintellix · Tymlos · UBRELVY · UNITHROID · UROLIFT · Utibron · VRAYLAR · VYVANSE · Vascepa · Veozah · WATCHMAN Access System · WATCHMAN FLX · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · Xhance · Xofluza · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in FL.
Equivalent to $83 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
185
Per 100K population
47.7
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Langford Tunkle is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 2%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Langford Tunkle experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Langford Tunkle performed 8,761 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Langford Tunkle receive payments from pharmaceutical companies?
Yes. Dr. Langford Tunkle received a total of $17,891 from 77 companies across 992 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Langford Tunkle's costs compare to other family medicines in Naples?
Dr. Langford Tunkle's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Langford Tunkle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Naples
Browse family medicines in Naples ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in FL
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in FL
Which FL family medicines receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology